Humane Genomics has developed a platform to engineer cancer killing viruses. We have taken a first principles approach to design and make oncolytic viral therapies. Using a highly lytic RNA virus engineered with "2 factor authentication" (using selective infection and selective replication) they have an on-target to off-target kill ratio > 1000. We are working on our first indication, pediatric liver cancer (hepatoblastoma), with our partners at Texas Children's Hospital, who are world leading experts. We have in vivo (mouse) data showing safety and currently developing efficacy data and are showing 50% reduction in tumor volume.
Pricing details are tailored to specific treatment plans and research needs. Contact us for a customized quote.
Our team at Humane Genomics is dedicated to harnessing the power of synthetic biology to engineer cancer-killing viruses. We bring together experts in computer-aided design, DNA synthesis, and cell transfection to create state-of-the-art oncolytic viral therapies.
Finding the right cancer drug for each patient.
Adventris makes cancer vaccines
Cofactor closes the precision medicine gap with predictive diagnostics
Match with like-minded professionals for 1:1 conversations
Go from Slack Chaos to Clarity in Minutes
Personalize 1000s of landing pages in under 30 mins
The first LLM for document parsing with accuracy and speed
AI Assistants for SaaS professionals
AI-powered phone call app with live translation
Delightful AI-powered interactive demos—now loginless
AI Motion Graphics Copilot
Pop confetti to get rid of stress & anxiety, 100% AI-free
Smooth payments for SaaS